Revenue News - Candlesense

Knightscope Signs Another $1M in Renewals, Expansions and New Sales Won

(NASDAQ:KSCP) SUNNYVALE, Calif.--(BUSINESS WIRE)--Knightscope, Inc. (NASDAQ: KSCP), a leader in autonomous security robots and emergency communication devices, today announced that it has signed an...

Symbol: KSCP

6 days ago

Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow

WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, g...

How might this revenue guidance influence analyst coverage, target price revisions, and overall market sentiment toward TVGN? What is the projected earnings‑per‑share (EPS) impact of the $1 billion launch year on the bottom line? How does the company’s cost‑efficient drug development model translate into lower R&D spend versus peers?

Symbol: TVGN

about 1 month ago